You are here
Presentation by Dr. Capucine Morelot at the TAO Congress on 19/20 November 2015
According to the definition in the 1999 consensus statement of the American Thoracic Society, dyspnoea is “a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity”. Dyspnoea is a frequent and disabling symptom. With regard to cancer patients, it occurs mainly in lung cancer, head and neck cancer as well as breast cancer. Dr. Capucine Morelot explains the pathophysiology and the psychophysiology of dispnoea. She presents the instruments for evaluating dyspnoea in cancer as well as various treatment options. The only recognized therapy are opioids; however, several treatment options which interfere with the neurophysiology are currently being investigated. The treatment of cancer patients with dyspnoea requires a multidisciplinary approach which involves physicians as well as physical and occupational therapists.
Dr. Capucine Morelot, Pitié Salpêtrière, Paris, France